Showing results (81-90 of 290) with videos related to
Sort By:
Pageof 29
Journal of Virology|December 18, 2015
Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR PathwaySowmya Pattabhi, Courtney R Wilkins, Ran Dong, et al.Cell Reports|September 19, 2019
A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus ChallengeCourtney Woolsey, Andrea R Menicucci, Robert W Cross, et al.Clinics in Laboratory Medicine|July 4, 2006
Viral hemorrhagic feversAileen M Marty, Peter B Jahrling, Thomas W GeisbertAntiviral Research|August 18, 2016
Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodiesRobert W Cross, Chad E Mire, Luis M Branco, et al.Journal of Bioterrorism & Biodefense|January 31, 2012
Vesicular Stomatitis Virus-Based Vaccines for Prophylaxis and Treatment of Filovirus InfectionsAndrea Marzi, Heinz Feldmann, Thomas W Geisbert, et al.Expert Opinion on Drug Discovery|October 2, 2018
Small animal models of filovirus disease: recent advances and future directionsRobert W Cross, Karla A Fenton, Thomas W GeisbertThe Journal of Infectious Diseases|July 9, 2018
Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman PrimatesPavlo Gilchuk, Chad E Mire, Joan B Geisbert, et al.Scientific Reports|February 22, 2020
Immune correlates of postexposure vaccine protection against Marburg virusCourtney Woolsey, Allen Jankeel, Demetrius Matassov, et al.Journal of Virology|September 25, 2009
Glycoprotein-dependent acidification of vesicular stomatitis virus enhances release of matrix proteinChad E Mire, Derek Dube, Sue E Delos, et al.The Journal of Infectious Diseases|December 6, 2007
Epitopes required for antibody-dependent enhancement of Ebola virus infectionAyato Takada, Hideki Ebihara, Heinz Feldmann, et al.Pageof 29